Rabies Antibody Screen by RFFIT, Serum
Also known as: RABIES AB
Use
This test measures the immune response to rabies vaccination by determining the presence and titers of rabies antibodies in the serum. It is crucial for assessing the effectiveness of rabies vaccination and determining if the antibody levels meet the acceptable response guidelines set by the World Health Organization (WHO). A result of 0.5 IU/mL or higher is deemed an acceptable response according to WHO guidelines.
Special Instructions
Not provided.
Limitations
The rabies antibody screen by RFFIT may not detect antibody levels below 0.1 IU/mL, which is considered below the detection limit. The accuracy of the test can be affected by factors such as the time elapsed since vaccination and the individual's immune response. Results should be interpreted in the context of clinical history and other laboratory findings. This assay is compliant with non-ARUP laboratory standards and is New York state approved.
New York Approved
Methodology
Other
Biomarkers
Rabies Antibody
Analyte
LOINC Codes
- 6527-6 - RABV NAb Spec Nt-aCnc
Result Turnaround Time
21-31 days
Related Documents
For more information, please review the documents below
Specimen
Serum
Volume
2 mL
Minimum Volume
1 mL
Container
Plain red or serum separator tube (SST). ARUP standard transport tube for submission.
Storage Instructions
Frozen. Also acceptable: Room temperature or refrigerated.
Stability Requirements
| Temperature | Period |
|---|---|
| Room Temperature | 1 week |
| Refrigerated | 2 weeks |
| Frozen | 1 month |
Other tests from different labs that may be relevant